Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
- PMID: 36835441
- PMCID: PMC9961468
- DOI: 10.3390/ijms24044029
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
Abstract
The purpose of this Special Issue is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidaemia, and cardiovascular disease [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Zlacká J., Murár M., Addová G., Moravčík R., Boháč A., Zeman M. Synthesis of Glycolysis Inhibitor PFK15 and Its Synergistic Action with an Approved Multikinase Antiangiogenic Drug on Human Endothelial Cell Migration and Proliferation. Int. J. Mol. Sci. 2022;23:14295. doi: 10.3390/ijms232214295. - DOI - PMC - PubMed
-
- Lee D., Tomita Y., Miwa Y., Shinojima A., Ban N., Yamaguchi S., Nishioka K., Negishi K., Yoshino J., Kurihara T. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury. Int. J. Mol. Sci. 2022;23:11228. doi: 10.3390/ijms231911228. - DOI - PMC - PubMed
-
- Lee D., Tomita Y., Miwa Y., Jeong H., Shinojima A., Ban N., Yamaguchi S., Nishioka K., Negishi K., Yoshino J., et al. Nicotinamide Mononucleotide Protects against Retinal Dysfunction in a Murine Model of Carotid Artery Occlusion. Int. J. Mol. Sci. 2022;23:14711. doi: 10.3390/ijms232314711. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
